E-LIB Suche - Ergebnisse für: Ganten, Tom Michael

1

Infektionen in der Gastroenterologie

UNI-MED SCIENCE

Ganten, Tom Michael ; Gyr, Niklaus - 1. Aufl . , 2004

Copies: Zentrale:Magazinturm E01 tr 1422; Zentrale:Magazin 01.j.7609

2

Infektionen in der Gastroenterologie

UNI-MED SCIENCE

Ganten, Tom Michael ; Geiss, Heinrich K.. - 1. Aufl . , 2004

Copies: Zentrale:Magazinturm E01 tr 1420; Zentrale:Magazin 01.j.7587

3

HCC recurrence in HCV‐infected patients after liver transpl..:

Werner, Jens M. ; Hornung, Matthias ; Krah, Rubertha...
Transplant International. 33 (2020) 8 - p. 917-924 , 2020

Link: https://doi.org/10.1111/..

4

Resminostat plus sorafenib as second-line therapy of advanc..:

Bitzer, Michael ; Horger, Marius ; Giannini, Edoardo G....
Journal of Hepatology. 65 (2016) 2 - p. 280-288 , 2016

Link: https://doi.org/10.1016/..

5

Phase II Study of First-Line Trebananib Plus Sorafenib in P..:

Abou-Alfa, Ghassan K. ; Blanc, Jean-Frederic ; Miles, Steven...
The Oncologist. 22 (2017) 7 - p. 780-e65 , 2017

Link: https://doi.org/10.1634/..

6

Emergence of oligoclonal t cell populations following thera..:

Jendro, Michael C. ; Ganten, Tom ; Matteson, Eric L...
Arthritis & Rheumatism. 38 (1995) 9 - p. 1242-1251 , 1995

Link: https://doi.org/10.1002/..

7

mTOR Inhibition Is Most Beneficial After Liver Transplantat..:

Schnitzbauer, Andreas A ; Filmann, Natalie ; Adam, René...
boreal:235479. , 2020

Link: http://hdl.handle.net/20..

8

mTOR Inhibition Is Most Beneficial After Liver Transplantat..:

Schnitzbauer, Andreas A ; Filmann, Natalie ; Adam, Rene...
https://research.rug.nl/en/publications/8e7b1c0b-f3e8-46a8-8f89-b139a2cf277a. , 2020

Link: https://hdl.handle.net/1..

9

Sirolimus Use in Liver Transplant Recipients With Hepatocel..:

Geissler, Edward K ; Schnitzbauer, Andreas A ; Zuelke, Carl...
https://research.rug.nl/en/publications/7a8b68d4-7dd2-47a4-be0b-67325219be7f. , 2016

Link: https://hdl.handle.net/1..

10

Sirolimus Use in Liver Transplant Recipients With Hepatocel..:

Geissler, Edward K ; Schnitzbauer, Andreas A ; Zuelke, Carl...
10.1097/TP.0000000000000965. , 2016

Link: http://hdl.handle.net/10..

11

Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driv..:

von Karstedt, Silvia ; Conti, Annalisa ; Nobis, Max...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591140/. , 2015

Link: http://www.ncbi.nlm.nih...

12

Phase II Study of First‐Line Trebananib Plus Sorafenib in P..:

Abou‐Alfa, Ghassan K ; Blanc, Jean‐Frederic ; Miles, Steven...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507650/. , 2017

Link: http://www.ncbi.nlm.nih...

13

Advance Care Planning in der Bundesrepublik Deutschland

Selbstbestimmung bis an das Lebensende? Einstellungen und E...

Dietz, Marcel , 22 Jul. 2024

Link: https://nbn-resolving.or..

14

Zur Reformbedürftigkeit des gegenwärtigen Allokationsmodu..

, In: Priorisierung in der Medizin / Björn Schmitz-Luhn ... (Hrsg.)

vom "Sickest First"-Prinzip zum "Most Lives Saved"-Ansatz

Dannecker, Gerhard. (2013) - p. 147-160

Copies: Zentrale:E02 a med 202 mb/808; TB BHV: mmt 200/138

15

WHO grade related expression of TRAIL-receptors and apoptos..:

Koschny, Ronald ; Krupp, Wolfgang ; Xu, Li-Xin...
Pathology - Research and Practice. 211 (2015) 2 - p. 109-116 , 2015

Link: https://doi.org/10.1016/..